Elevai Labs, Inc. (ELAB) Stock

NASDAQ: ELABDevelops novel therapies for rare diseases.

Elevai Labs stock price chart

ELAB stock quote & key statistics

Elevai Labs earnings per share

Income →
Earnings per share

Elevai Labs revenue & net income

Income →
RevenueNet income

Elevai Labs annual financials

Income statement →
Elevai Labs, Inc. revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2025$590,084-$7.7M-$186225.67
FY2024$2.5M-$6.2M—
FY2023$1.7M-$4.3M-$78576.99
FY2022$766,277-$1.8M—
FY2021$827-$784,739—

Fiscal year ending December 31. Source: company filings via EODHD.

About Elevai Labs, Inc.

Elevai Labs, Inc., based in Newport Beach, California, specializes in the development, manufacturing, and marketing of skincare products within the United States. Formerly known as Reactive Medical Labs Inc., the company rebranded to Elevai Labs, Inc. in December 2021, reflecting its focus on innovative skincare solutions. Established in 2020, Elevai Labs caters specifically to dermatologists, plastic surgeons, medical spa owners, and physicians specializing in aesthetic and therapeutic skincare.

The company's product lineup includes Empower and Enfinity, advanced post-skincare procedure care serums formulated for the face, neck, and upper chest regions. These specialized products are designed to enhance and prolong the benefits of skincare treatments, supporting skin health and rejuvenation post-procedure. Elevai Labs leverages cutting-edge research and development to ensure its skincare formulations meet the high standards of medical professionals and their discerning clientele.

Driven by a commitment to innovation and quality, Elevai Labs continues to expand its presence in the skincare industry. Through strategic partnerships and a dedicated focus on scientific advancements, the company aims to empower healthcare providers with effective solutions that optimize skincare outcomes and patient satisfaction.

Elevai Labs stock FAQ

What is the Elevai Labs stock ticker symbol?

Elevai Labs, Inc. trades on the NASDAQ under the ticker symbol ELAB.

What sector and industry is Elevai Labs in?

Elevai Labs, Inc. is classified in the Healthcare sector, Biotechnology industry.

How many employees does Elevai Labs have?

Elevai Labs, Inc. has about 32 full-time employees.

What were Elevai Labs's revenue and earnings last fiscal year?

Elevai Labs reported revenue of $590,084 and net income of -$7.7M in fiscal 2025, with earnings per share of -$186225.67. Revenue declined 76.1% from the prior year.

When did Elevai Labs go public?

Elevai Labs stock began trading on November 21, 2023.

Biotechnology stocks

All Healthcare stocks →